Evaluation of accuracy of three assays for human papillomavirus detection and typing: Hybrid Capture® 2, HPV Consensus kit® and Amplicor HPV®;Évaluation des performances de trois techniques de détection et de typage des papillomavirus humains : Hybrid Capture® 2, HPV Consensus kit® et Amplicor HPV®

Pathologie Biologie

Volumn 56, Issue 1, 2008, Pages 29-35

  Hantz, S ^a   Caly, H ^a   Decroisette, E ^a   Dutrop, A ^a   Bakeland, D ^b   Pascal, B ^b   Darreye, G ^b   Dussartre, C ^b   Renaudie, J ^c   Rogez, S ^a   Aubard, Y ^a   Denis, F ^a   Alain, S ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

^b Cabinet d'Anatomie et de Cytologie Pathologiques   (France)

^c clinique du Colombier   (France)

Author keywords

Detection; Genotyping; HPV; Hybrid capture; Hybridization; PCR

Indexed keywords

ARTICLE; BIOASSAY; EVALUATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NONHUMAN; VIRUS DETECTION; VIRUS TYPING; WART VIRUS; ANALYTICAL EQUIPMENT; CLASSIFICATION; COMPARATIVE STUDY; FEMALE; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; METHODOLOGY; NUCLEIC ACID HYBRIDIZATION; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX; VIROLOGY;

VIRUS DNA;

CERVIX UTERI; DNA, VIRAL; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; NUCLEIC ACID HYBRIDIZATION; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

EID: 39049106875     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2007.09.006     Document Type: Article

References (16)

1. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 12-19
2. Manos M.M., Ting Y., Wright D.K., Lewis A.J., Broker T.R., and Wolinsky S.M. Use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Cells 7 (1989) 209-214
3. Husnjak K., Grce M., Magdic L., and Pavelic K. Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens. J Virol Methods 88 (2000) 125-134
4. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25 (1997) 3389-3402
5. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 (2003) 518-527
6. Sandri M.T., Lentati P., Benini E., Dell'Orto P., Zorzino L., Carozzi F.M., et al. Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples. J Clin Microbiol 44 (2006) 2141-2146
7. Clavel C., Masure M., Putaud I., Thomas K., Bory J.P., Gabriel R., et al. Hybrid capture II, a new sensitive test for human papillomavirus detection. Comparison with hybrid capture I and PCR results in cervical lesions. J Clin Pathol 51 (1998) 737-740
8. Solomon D., Schiffman M., and Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 93 (2001) 293-299
9. Castle P.E., Wheeler C.M., Solomon D., Schiffman M., and Peyton C.L. Interlaboratory reliability of Hybrid Capture 2. Am J Clin Pathol 122 (2004) 238-245
10. Castle P.E., Schiffman M., Burk R.D., Wacholder S., Hildesheim A., Herrero R., et al. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types. Cancer Epidemiol Biomarkers Prev 11 (2002) 1394-1399
11. Longuet M., Beaudenon S., and Orth G. Two novel genital human papillomavirus (HPV) types, HPV68 and HPV70, related to the potentially oncogenic HPV39. J Clin Microbiol 34 (1996) 738-744
12. van Ham M.A., Bakkers J.M., Harbers G.K., Quint W.G., Massuger L.F., and Melchers W.J. Comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders. J Clin Microbiol 43 (2005) 2662-2667
13. Ronco G., Ghisetti V., Segnan N., Snijders P.J., Gillio-Tos A., Meijer C.J., et al. Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer 41 (2005) 297-305
14. Bergeron C., Cartier I., Guldner L., Lassalle M., Savignini A., and Asselain B. Lésions précancéreuses et cancers du col de l'utérus diagnostiqués par le frottis cervical, Ile-de-France, enquête Crisap, 2002. BEH 2 (2005) 5-6
15. Riethmuller D., Gay C., Bertrand X., Bettinger D., Schaal J.P., Carbillet J.P., et al. Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture 2 and polymerase chain reaction. Diagn Mol Pathol 8 (1999) 157-164
16. Bernard H.U. The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. J Clin Virol 32 (Suppl. 1) (2005) S1-S6